OCA
Asset Logo

Oceania Healthcare Limited

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💰 Dividends

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual growth

💰

0.00%
Annual dividend yield

Based on the most recent dividend

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

2
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Oceania Healthcare Ltd. engages in the provision of health care solution. The firm operates through three segments. The care segment is engaged in providing products, such as traditional care beds and care suites. The segment is involved in the provision of accommodation, care and related services to the Company’s aged care residents; and services, such as meals and care packages to independent living residents. The village operations segment is engaged in providing products, such as independent living and rental properties. The segment is involved in the provision of accommodation and related services to independent residents in the Company’s retirement villages. The other segment is involved in the provision of support services to the Company, which includes administration, marketing and operations. In addition, this segment includes the provision of training by the Wesley Institute of Learning.

📈 Performance

Price History

+2.05%

1M

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💰 Dividends

Payouts

💰 Annual Dividend Yield*

0.00%

💰 Annual Dividend Earnings Per $1,000 invested**

$0.00

💰 Most Recent Dividend Franked Percentage Estimate

0.00%

💰 Average Dividend Franked Percentage Estimate

0.00 %

💰 Dividend reinvestment

Learn more

* Based on the most recent dividend

** Calculated by multiplying the most recent dividend yield by $1,000

Dividend History

1Y

5Y

10Y

Graph

Table

Year
Yearly Dividend Earnings Per Share
Franking Estimate

2024

$0.00

0.00%

2023

$0.00

0.00%

2022

$0.03

0.00%

2021

$0.04

0.00%

2020

$0.03

0.00%

2019

$0.04

0.00%

2018

$0.04

0.00%

2017

$0.00

0.00%

2016

$0.00

0.00%

2015

$0.00

0.00%

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

0%
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.74

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in OCA

2

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in OCA

828 days
OCA investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

100%
🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in OCA also invest in...

Vanguard Australian Shares Index Etf

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

📊 Share price

$90.18 AUD

NULL AUSTRALIA

NULL BETA

Find Out More

ROBO

ROBO.AX was created on 2017-09-13 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the ROBO.AX Global Robotics and Automation Index (the Index)

📊 Share price

$74.40 AUD

NULL GLOBAL

NULL SMART BETA

NULL ETHICAL

NULL THEMATIC

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

📊 Share price

$104.08 AUD

NULL GLOBAL

NULL EX AUSTRALIA

NULL BETA

QUAL

QUAL.AX was created on 2014-10-29 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. Each Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.

📊 Share price

$43.79 AUD

NULL GLOBAL

NULL SMART BETA

NULL EX AUSTRALIA

FAIR

FAIR.AX was created on 2017-11-27 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes Australian companies that have passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

📊 Share price

$18.55 AUD

NULL AUSTRALIA

NULL NEW ZEALAND

NULL ETHICAL

NULL THEMATIC

NULL SUSTAINABLE

Want more shares? Try these...

Orthocell Ltd. engages in the development and commercialization of cell therapies and related technologies. The company is headquartered in Perth, Western Australia. The company went IPO on 2014-08-12. The firm is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes CelGro, Striate+, Remplir, and SmrtGraft. CelGro is a collagen medical device that facilitates tissue reconstruction and healing in a variety of dental and orthopedic reconstructive applications. CelGro is manufactured using a SMRT manufacturing process to preserve the natural collagen structure. Striate+ is used for dental GBR applications. Remplir is for peripheral nerve reconstruction. SmrtGraft is for tendon repair. Its other major products are autologous cell therapy, which focuses on regenerating damaged tendon and cartilage tissue. The company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.

📊 Share price

$0.37 AUD

Objective Corp. Ltd. engages in the supply of information technology software and services. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2000-08-17. The Company’s Objective Content Solutions products enable customers to manage information and process governance across the enterprise. The company also enables customers to collaborate with external organizations with the security, information governance and auditability demanded by the government. Its Objective Keystone products improve efficiency and deliver government in the process of authoring, reviewing, engaging with and publishing documents. Its Objective RegWorks and Objective Reach products are focused on the delivery of government regulation technology solutions. Its Objective Planning Solutions include Objective Trapeze products, which digitally transform development application plan reviews and assessments, and Objective Alpha and Master Business Systems, which provide end-to-end building consenting solutions.

📊 Share price

$13.83 AUD

Omni Bridgeway Ltd. engages in the investigation, management and funding of litigation and arbitration claims. The company is headquartered in Adelaide, South Australia and currently employs 199 full-time employees. The company went IPO on 2000-01-28. The firm is engaged in dispute finance, financing disputes from inception through trial, appeal, enforcement and recovery. The firm provides solutions, including arbitration financing, judgement enforcement, distressed asset recovery, bankruptcy, commercial, intellectual property, investor recoveries, class/group actions, appeals, and whistleblower. Arbitration financing analyzes factors impacting claims and advises on navigating the various arbitral institutions. Judgement enforcement advises clients on how to safeguard collectability and enforcement of foreign judgments. Bankruptcy offers pre-litigation and pre-confirmation investigations, working capital, fees and credit funding and monetizing appeals. The company assesses investments and enforcement opportunities in Africa, Asia, Australia, Canada, Europe, Latin America, the Middle East, the United Kingdom, and others.

📊 Share price

$2.70 AUD

Ora Banda Mining Ltd. engages in the development and exploration of gold. The company is headquartered in Perth, Western Australia. The company went IPO on 2002-10-29. The firm is engaged in mineral exploration, mine development and operation and the sale of gold in Western Australia. Its projects include Davyhurst, Riverina-Mulline, Siberia, Callion, Walhalla, and Lady Idaa. The Davyhurst Gold Project is located approximately 120 kilometers north-west of Kalgoorlie, within the tier one gold mining province of the Eastern Goldfields in Western Australia. The Company’s tenement package consists of approximately 92 granted tenements covering an area of approximately 1,200 square kilometers (km2). The company offers a coverage of approximately 130 strike kilometers of greenstone sequences prospective for gold as well as nickel sulfide and base metal mineralization. The Riverina-Mulline Project area is approximately 44 drive-km north of the Davyhurst processing plant. The Callion Project area is located approximately 13 km south-west of the Davyhurst processing plant.

📊 Share price

$0.14 AUD
Compare
Add to watchlist